Kryger Capital’s SpringWorks Therapeutics SWTX Stock Holding History

Kryger Capital’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-765,522	Closed	-$36M	–	42
2025 Q2	$36M	Buy	765,522 +683,859	+837%	+$30.4M	6.66%	5
2025 Q1	$3.6M	Buy	+81,663	New	+$3.76M	0.42%	17

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kryger Capital's SWTX Position: Q3 2025 in Review

Kryger Capital sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 765,522 shares — an estimated $36M sold.

Kryger Capital first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $36M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Kryger Capital reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Kryger Capital sold 765,522 SpringWorks Therapeutics shares in Q3 2025, an estimated $36M.
Kryger Capital first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Kryger Capital's SpringWorks Therapeutics position peaked at $36M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Kryger Capital's 13F filing for Q3 2025, filed 14 Nov 2025.